Clinical Trials on Advanced and Metastatic Breast Cancer
Total 52224 results
-
Institut CurieCompletedMetastatic Breast Cancer, HER2 Negative Primary TumorFrance
-
Ana C Garrido-Castro, MDMerck Sharp & Dohme LLC; Gilead SciencesActive, not recruitingMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | HR-Positive Breast CancerUnited States
-
AstraZenecaNot yet recruiting
-
The First Affiliated Hospital with Nanjing Medical...Zhejiang Cancer HospitalRecruiting
-
Erasmus Medical CenterUniversity Medical Center Groningen; Leiden University Medical CenterRecruitingAdvanced Breast CancerNetherlands
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
CSPC Ouyi Pharmaceutical Co., Ltd.Not yet recruiting
-
Fujian Medical University Union HospitalNot yet recruitingAdvanced Breast Cancer
-
Cancer Institute and Hospital, Chinese Academy...Jiangsu HengRui Medicine Co., Ltd.Not yet recruiting
-
Liaoning Tumor Hospital & InstituteRecruiting
-
Haihe Biopharma Co., Ltd.Not yet recruiting
-
Stanford UniversityPfizerRecruitingBreast Cancer | Advanced Breast CancerUnited States
-
Centre Oscar LambretLaboratoire PRISM - Michel SALZETRecruitingAdvanced Breast CancerFrance
-
Fudan UniversityRecruiting
-
Duke UniversityTerminatedAdvanced Breast CancerUnited States
-
EQRx, Inc.TerminatedAdvanced Breast CancerUnited States, Georgia, Belgium, Italy, Mexico, Moldova, Republic of
-
MedSIRCellestia Biotech AGTerminated
-
RemeGen Co., Ltd.Completed
-
Novartis PharmaceuticalsCompletedAdvanced Breast CancerBelgium, Italy, Czechia, Hungary, Canada, Netherlands, Germany, Singapore, Australia, Denmark, Poland, Switzerland, Korea, Republic of, Spain, Thailand, Lebanon, Austria, Bulgaria, Russian Federation, Norway, Jordan, United States, ... and more
-
BeBetter Med IncXiangya Hospital of Central South University; Hunan Cancer HospitalActive, not recruiting
-
MedSIRWithdrawn
-
Guardant Health, Inc.CompletedGuardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer (GRECO-B)Advanced Breast CancerUnited States
-
Taizhou EOC Pharma Co., Ltd.Active, not recruiting
-
Yale UniversityMerck Sharp & Dohme LLCCompletedAdvanced Breast CancerUnited States
-
Duke UniversityBristol-Myers SquibbCompleted
-
PfizerTerminatedAdvanced Breast CancerUnited States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa
-
Istituto Clinico HumanitasUnknown
-
Institut fuer FrauengesundheitEisai GmbHRecruitingAssessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer (AIRE)Breast Cancer Female | Breast Cancer Metastatic | Neoplasm, BreastGermany
-
MedSIRDaiichi SankyoRecruitingMetastatic Breast Cancer | Solid Tumor, Adult | Advanced Non-Small Cell Squamous Lung CancerSpain, Austria
-
Hoffmann-La RocheActive, not recruitingInflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerCanada, Croatia, Spain, Argentina, Mexico, Korea, Republic of, Bosnia and Herzegovina, Brazil, Costa Rica, Turkey, Singapore, Bulgaria, South Africa, India, Peru, Kenya, Chile
-
Icahn School of Medicine at Mount SinaiTerminatedLocally Advanced Breast CancerUnited States
-
PfizerCompletedAdvanced Breast Cancer FemaleMexico, Argentina, Brazil, Colombia
-
Novartis PharmaceuticalsCompletedLocally Advanced Breast CancerBrazil
-
University of MiamiRecruitingBreast Cancer | Metastatic Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Dana-Farber Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI); Gateway for Cancer... and other collaboratorsRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Fudan UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerChina
-
University of RochesterJohns Hopkins UniversityCompletedMetastatic Breast Cancer | Breast Cancer Stage IVUnited States
-
Korean Cancer Study GroupUnknownPhase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast CancerMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Meabco A/SMeddoc; Norwegian University of Life SciencesCompletedMetastatic Breast Cancer | Stage IV Breast CancerThailand, Russian Federation
-
CSPC Ouyi Pharmaceutical Co., Ltd.Not yet recruitingAdvanced Breast CancerChina
-
Li HuipingNot yet recruiting
-
Wenjin YinRecruitingAdvanced Breast CancerChina
-
Seoul National University HospitalNot yet recruitingAdvanced Breast CancerKorea, Republic of
-
Seoul National University HospitalRecruitingAdvanced Breast CancerKorea, Republic of
-
Spanish Breast Cancer Research GroupAstraZenecaCompleted
-
Abramson Cancer Center at Penn MedicineCompletedAdvanced Breast CancerUnited States
-
Spanish Breast Cancer Research GroupNovartisCompleted
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Breast CancerKorea, Republic of, Taiwan, Hong Kong, United States, Japan, Croatia, United Kingdom, Hungary, Australia, Canada, Serbia, Singapore, South Africa, Poland, Spain, Russian Federation, Romania, Austria, Belgium, Bulgaria, Czechia, Fr... and more